Anti-CD20 Reference Antibody is expressed from CHO. The heavy chain type is huIgG1, and the light chain type is hukappa. It has a predicted MW of 146.32 kDa.
Anti-CD20 Reference Antibody (rituximab) on SDS-PAGE under reducing (R) condition. The gel was stained with Coomassie Blue. The purity of the protein is greater than 95%.
The purity of Anti-CD20 Reference Antibody (rituximab)is more than 98.97% ,determined by SEC-HPLC.
Immobilized human EGFR His at 2 µg/mL can bind Anti-CD20 Reference Antibody (rituximab),EC50=0.01573/0.01258µg/mL.
Raji cells were stained with Anti-CD20 Reference Antibody (rituximab) and negative control protein respectively, washed and then followed by PE and analyzed with FACS, EC87=1.334 µg/mL.
Anti-CD20 Reference Antibody (rituximab)-induced CDC activity was evaluated using Raji Cell. The max Lysis rate was approximately 74%.
Anti-CD20 Reference Antibody (rituximab)-induced ADCC activity was evaluated using Raji Cell. The max Lysis rate was approximately 35%.
* VAT and and shipping costs not included. Errors and price changes excepted